These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
108 related articles for article (PubMed ID: 5952626)
1. [Comment on the subject of MD 2028 in psychiatric emergencies]. Burner M Praxis; 1966 Jan; 55(2):50. PubMed ID: 5952626 [No Abstract] [Full Text] [Related]
2. [Clinical observations of Luvatren therapy]. Gastager H Nord Psykiatr Tidsskr; 1968; 22(2):106-11. PubMed ID: 5704625 [No Abstract] [Full Text] [Related]
4. [ year of experimentation with haloanisone, MD 2028, in geronto-psychiatry]. Villa JL; Pasini W Praxis; 1966 Jan; 55(2):46-9. PubMed ID: 5952625 [No Abstract] [Full Text] [Related]
5. [A new treatment in current psychiatric practice: Sedalium]. Dubois JC; Dacharry JC; Demoures JM Ann Med Psychol (Paris); 1970 Feb; 1(2):276-93. PubMed ID: 5420925 [No Abstract] [Full Text] [Related]
6. [Apropos of the use of 2028 M.D. in general surgery and neurosurgery]. Goutelle A; Dechaume JP; Fischer G Clinique (Paris); 1965 Dec; 60(614):801-3. PubMed ID: 5860812 [No Abstract] [Full Text] [Related]
7. [Clinical use of butyrophenones]. Gerle B Nord Psykiatr Tidsskr; 1968; 22(2):100-6. PubMed ID: 5704624 [No Abstract] [Full Text] [Related]
9. [THERAPEUTIC EFFECTS OF MD 20-28 (BUTYROPHENONE PIPERAZINATE) IN THE PSYCHIATRIC FIELD]. MONTEVERDI T Rass Neuropsichiatr; 1963; 17():283-307. PubMed ID: 14127200 [No Abstract] [Full Text] [Related]
10. [Pharmacologic and clinico-comparative study between modern sedatives in relation to the classic sedatives]. Monteverdi T; Marino A Rass Neuropsichiatr; 1965; 19(2):254-79. PubMed ID: 5886816 [No Abstract] [Full Text] [Related]
11. [Clinical study of a new drug with neuro-spasmolytic action in digestive pathology]. Miniconi P; Perrin D; Nédelec G; Legeais M Bord Med; 1971 Nov; 4(11):3329-38. PubMed ID: 5136885 [No Abstract] [Full Text] [Related]
12. [Preliminary report of Luvatren treatment in neuroses]. Bartholdson E Nord Psykiatr Tidsskr; 1968; 22(2):116-8. PubMed ID: 5704627 [No Abstract] [Full Text] [Related]
13. [Neuroleptic drugs]. Mårtens S Nord Med; 1967 Dec; 78(50):1639-43. PubMed ID: 4294514 [No Abstract] [Full Text] [Related]
14. A survey of prescribing patterns in common psychiatric conditions. Morris PA Practitioner; 1971 May; 206(235):669-72. PubMed ID: 5579787 [No Abstract] [Full Text] [Related]
15. [Study of the hypnotic properties of a new benzodiazepine, Mogadon. 1. Study in normal volunteers and psychiatric patients]. Tétreault L; Richer P; Juretic A; Bordeleau JM Union Med Can; 1966 Jan; 95(1):45-9. PubMed ID: 5323126 [No Abstract] [Full Text] [Related]
16. [Buronil, a new butyrophenone derivative for acute psychiatric disorders. A comparison with chlorpromazine and chlorprothixene]. Haugen T Ugeskr Laeger; 1967 Sep; 129(37):1194-7. PubMed ID: 5584977 [No Abstract] [Full Text] [Related]
17. [Experience with the butyrophenone Luvatren in schizophrenia therapy]. Weiser G Nord Psykiatr Tidsskr; 1968; 22(2):111-6. PubMed ID: 5704626 [No Abstract] [Full Text] [Related]
18. [Prolonged narcosis as psychiatric treatment: the case of somnifen]. Med Hist (Barc); 2008; (1):9-15. PubMed ID: 20506623 [No Abstract] [Full Text] [Related]
19. [Treatment of neurosympathetic dystonia with the methylperidol-hexadiphane combination]. Duboureau LH; Saby G Rev Corps Sante Armees Terre Mer Air; 1971 Aug; 12(4):459-63. PubMed ID: 4256776 [No Abstract] [Full Text] [Related]
20. [Clinical neuroleptic tests in the case of the butyrophenone derivatives benzperidol and spiroperidol]. Haase HJ; Mattke D; Schönbeck M Psychopharmacologia; 1964 Dec; 6(6):435-52. PubMed ID: 5830963 [No Abstract] [Full Text] [Related] [Next] [New Search]